6-(Cyclohexylmethoxy)-3H-purin-2-amine(CAS: 161058-83-9)

Regulatory guidelines applicable to 6-(Cyclohexylmethoxy)-3H-purin-2-amine (CAS: 161058-83-9) include GHS classification for hazardous chemicals, REACH regulations for identification, registration, evaluation, and authorization of substances, and FDA/EPA requirements for safety and environmental impact assessments. Ensure compliance with local and international regulations for its production, handling, and disposal.

Alternatives to 6-(Cyclohexylmethoxy)-3H-purin-2-amine (CAS: 161058-83-9) in synthesis include other purine derivatives such as 6-aminopurine and analogs like 6-(2-methylcyclohexylmethoxy)-3H-purin-2-amine. Common alternative reagents include methylamine and cyclohexanol, which can be used as substitutes in certain chemical processes.

The market and research trend for 6-(Cyclohexylmethoxy)-3H-purin-2-amine (CAS: 161058-83-9) indicates growing interest in its potential applications in pharmaceuticals and biotechnology. Recent research focuses on its use as a nucleoside analog for antiviral and anticancer drugs. Market trends show increasing demand from pharmaceutical companies for development and commercialization of related products.

Waste containing 6-(Cyclohexylmethoxy)-3H-purin-2-amine (CAS: 161058-83-9) should be collected in sealed, labeled containers and stored in a secure, well-ventilated area. For disposal, consult with a licensed hazardous waste management service. Incineration is a common method, but ensure compliance with local regulations. Implement environmental protection measures to prevent contamination during handling and disposal.